Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPR35 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
mRNA | RGS12 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-06 |
mRNA | B3GNT9 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
mRNA | SYDE1 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-06 |
mRNA | ARAP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | SOX9 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | CYLD | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | POFUT2 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |